AC Immune (ACIU) Debt to Equity (2017 - 2019)
AC Immune (ACIU) has disclosed Debt to Equity for 3 consecutive years, with $0.0 as the latest value for Q4 2019.
- On a quarterly basis, Debt to Equity fell 17.94% to $0.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $0.0, a 17.94% decrease, with the full-year FY2019 number at $0.0, down 17.94% from a year prior.
- Debt to Equity was $0.0 for Q4 2019 at AC Immune, down from $0.0 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.0 in Q4 2017 to a low of $0.0 in Q4 2019.
- A 3-year average of $0.0 and a median of $0.0 in 2018 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: tumbled 31.03% in 2018, then decreased 17.94% in 2019.
- AC Immune's Debt to Equity stood at $0.0 in 2017, then crashed by 31.03% to $0.0 in 2018, then fell by 17.94% to $0.0 in 2019.
- Per Business Quant, the three most recent readings for ACIU's Debt to Equity are $0.0 (Q4 2019), $0.0 (Q4 2018), and $0.0 (Q4 2017).